Therapy & Business Area Training for Pharmaceutical, Medical Technology & Biotechnology Professionals
![](/46/pdcnewsitem/03/29/98/VB1wq3a62mxV8Xy.jpg)
Industry professionals progress rapidly with face-to-face learning from leading physicians and experts.
Healthcare Education Services continues to be the leading provider of education programmes to the pharmaceutical, medical device, medical diagnostics and biotechnology industries. Industry professionals gain from Healthcare’s face-to-face, small group learning and high calibre education programmes in subject areas including Pricing & Reimbursement, Oncology, Cardiology, Asthma & COPD, Alzheimer’s Disease, Diabetes, Psychiatric Disorders and Health Economics. Delegates benefit from traditional lectures, discussion and Q&A with Healthcare’s eminent speakers.
“Rapid and progressive learning enables delegates to extend their knowledge fast encouraging the ability to discuss a subject credibly and confidently," explained Valerie Smith, Medical Education Director at Healthcare.
Healthcare’s course information and booking can be found at healthcare-ed.com. Courses in 2014 for open enrolment are held in central London apart from Oncology Clinical Experience, which is an exclusive and unique, hospital-based opportunity for training in a hospital setting, combining traditional lectures with practical example and takes place in Leeds, UK.
Pricing & Reimbursement: An Introduction, 4–5 March
Asthma & COPD: An Overview, 12–13 March
Biomarkers: Their Application in Clinical Trials, 19–20 March
Alzheimer’s Disease: An Overview, 26–27 March
Epilepsy: An Overview, 2–3 April
Diabetes: An Overview, 2–3 April
Psychiatric Disorders: An Overview, 13–14 May
Introduction to Oncology and Its Treatment, 21–22 May
Cardiovascular Medicine: An Overview, 8–9 Oct
Immunotherapies: An Overview, 6 Nov
Oncology Clinical Experience Programme, 11–14 Nov
Oncology: Phase III Trials, 14–15 Nov
Haematological Malignancies, 18–19 Nov
Breast Cancer: Treatment & Management, 27 Nov
Health Economics for Pharmaceutical Personnel, 2–3 Dec
Medical education programmes developed by Healthcare Education Services are approved by the Faculty of Pharmaceutical Medicine for Continuing Professional Development (CPD) accreditation. They are ideal for personnel working in clinical research, medical information and regulatory affairs, biometrics, strategic marketing and other key industry roles.
Healthcare offers training for open enrolment and private commission. Open enrolment training is held in central locations with easy travel access. Privately commissioned programmes are held at a venue of client choice with the programme tailored to meet client objectives. Courses are held across the UK, Europe, US and worldwide.
Related News
-
News Ophthalmologic drug product Eylea faces biosimilar threats after FDA approvals
Regeneron Pharmaceutical’s blockbuster ophthalmology drug Eylea is facing biosimilar competition as the US FDA approves Biocon’s Yesafili and Samsung Bioepis/Biogen’s Opuviz. -
News ONO Pharmaceutical expands oncology portfolio with acquisition of Deciphera
ONO Pharmaceutical, out of Japan, is in the process of acquiring cancer-therapy maker Deciphera Pharmaceuticals for US$2.4 billion. -
News First offers for pharma from Medicare drug price negotiations
Ten high-cost drugs from various pharma manufacturers are in pricing negotiations in a first-ever for the US Medicare program. President Biden’s administration stated they have responded to the first round of offers. -
News Eli Lilly’s Zepbound makes leaps and bounds in weight-loss drug market
In the last week, Eli Lilly has announced their partnership with Amazon.com’s pharmacy unit to deliver prescriptions of Zepbound. Zepbound has also surpassed Novo Nordisk’s Wegovy for the number of prescriptions for the week of March 8.&nbs... -
News Chasing new frontiers at LEAP – The National Biotechnology Strategy Keynote
On the third day of LEAP (4–7 March 2024, Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia) the CPHI Middle East team hosted the Future Pharma Forum, to set the scene for an exciting new event for the pharma community, coming to Riya... -
News Pfizer maps out plans for developing new oncology therapeutics by 2030
Pfizer dilvulges plans to investors around growing their cancer portfolio, and the drugs they will be focusing on developing after their aquisition of Seagen in 2023. -
News Generics threat to Merck’s Bridion as Hikma seeks pre-patent expiry approval
Merck has disclosed they received notice from Hikma Pharmaceuticals for seeking a pre-patent expiry US FDA approval for Hikma’s generic version of Merck’s Bridion. -
News Bernie Sanders vs Big Pharma - the latest on drug price negotiations
In a hearing in front of the US Senate, three of the biggest pharmaceutical companies in America are challenged over exorbitant prescription drug prices, with Sanders claiming their actions are limiting the population's access to affordable healthc...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance